blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0512831

EP0512831 - Fibrinogen receptor antagonists [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.07.2000
Database last updated on 12.07.2024
Most recent event   Tooltip06.08.2004Lapse of the patent in a contracting state
New state(s): LU		published on 22.09.2004  [2004/39]
Applicant(s)For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000 Rahway
New Jersey 07065-0900 / US
[N/P]
Former [1999/38]For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Former [1992/46]For all designated states
MERCK & CO. INC.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Inventor(s)01 / Duggan, Mark E.
300 North Essex Avenue, Apt. 205B
Narberth, PA 19072 / US
02 / Ihle, Nathan
2416 Rickert Road
Perkasie, PA 18944 / US
03 / Hartman, George
1529 Tennis Circle
Lansdale, PA 19446 / US
04 / Turchi, Laura M.
214 Croft Ridge Drive
Broomal, PA 19008 / US
05 / Egbertson, Melissa S.
1232 Lois Road
Ambler, PA 19002 / US
06 / Hoffman, William F.
740 Weikel Road
Lansdale, PA 19446 / US
[1992/46]
Representative(s)Thompson, John, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1992/46]Thompson, John Dr., et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date92304113.107.05.1992
[1992/46]
Priority number, dateUS1991069689307.05.1991         Original published format: US 696893
US1991072035725.06.1991         Original published format: US 720357
US1992087126223.04.1992         Original published format: US 871262
[1992/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0512831
Date:11.11.1992
Language:EN
[1992/46]
Type: B1 Patent specification 
No.:EP0512831
Date:22.09.1999
Language:EN
[1999/38]
Search report(s)(Supplementary) European search report - dispatched on:EP04.09.1992
ClassificationIPC:C07D401/06, C07D211/76, C07D417/06, C07D401/14, C07D453/06, A61K31/445, A61K31/495, A61K31/54
[1992/46]
CPC:
C07D401/06 (EP,KR,US); A61P7/02 (EP); C07D211/76 (EP,US);
C07D401/14 (EP,US); C07D417/06 (EP,US); C07D453/06 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   PT,   SE [1992/46]
TitleGerman:Fibrinogen-Rezeptor-Antagonisten[1992/46]
English:Fibrinogen receptor antagonists[1992/46]
French:Antagonistes des récepteurs fibrinogeniques[1992/46]
Examination procedure06.04.1993Examination requested  [1993/23]
28.11.1996Despatch of a communication from the examining division (Time limit: M06)
24.05.1997Reply to a communication from the examining division
22.01.1998Despatch of a communication from the examining division (Time limit: M06)
18.07.1998Reply to a communication from the examining division
14.12.1998Despatch of communication of intention to grant (Approval: Yes)
30.03.1999Communication of intention to grant the patent
09.07.1999Fee for grant paid
09.07.1999Fee for publishing/printing paid
Opposition(s)24.06.2000No opposition filed within time limit [2000/36]
Fees paidRenewal fee
07.04.1994Renewal fee patent year 03
31.05.1995Renewal fee patent year 04
31.05.1996Renewal fee patent year 05
02.06.1997Renewal fee patent year 06
02.06.1998Renewal fee patent year 07
31.05.1999Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.09.1999
BE22.09.1999
CH22.09.1999
GR22.09.1999
LI22.09.1999
NL22.09.1999
SE22.09.1999
DK22.12.1999
PT22.12.1999
LU07.05.2000
[2004/39]
Former [2004/07]AT22.09.1999
BE22.09.1999
CH22.09.1999
GR22.09.1999
LI22.09.1999
NL22.09.1999
SE22.09.1999
DK22.12.1999
PT22.12.1999
Former [2003/45]AT22.09.1999
BE22.09.1999
CH22.09.1999
LI22.09.1999
NL22.09.1999
SE22.09.1999
DK22.12.1999
PT22.12.1999
Former [2003/07]AT22.09.1999
BE22.09.1999
CH22.09.1999
LI22.09.1999
NL22.09.1999
SE22.09.1999
PT22.12.1999
Former [2002/23]AT22.09.1999
BE22.09.1999
CH22.09.1999
LI22.09.1999
SE22.09.1999
PT22.12.1999
Former [2000/52]AT22.09.1999
BE22.09.1999
CH22.09.1999
LI22.09.1999
PT22.12.1999
Former [2000/50]AT22.09.1999
BE22.09.1999
PT22.12.1999
CH27.12.1999
LI27.12.1999
Former [2000/26]AT22.09.1999
BE22.09.1999
PT22.12.1999
Former [2000/24]AT22.09.1999
BE22.09.1999
Documents cited:Search[Y]EP0372486  (HOFFMANN LA ROCHE [CH]) [Y] 1-26 * the whole document *;
 [PY]US5064814  (KLEIN SCOTT I [US], et al) [PY] 1-26* the whole document *;
 [PA]EP0478362  (MERCK & CO INC [US]) [PA] 1-26 * the whole document *;
 [PA]EP0478328  (MERCK & CO INC [US]) [PA] 1-26 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.